Elizabeth David
Concepts (325)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 25 | 2026 | 141 | 9.570 |
Why?
| | Pneumonectomy | 29 | 2025 | 158 | 7.550 |
Why?
| | Lung Neoplasms | 45 | 2025 | 2560 | 6.530 |
Why?
| | Thoracic Surgical Procedures | 15 | 2025 | 92 | 6.390 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 31 | 2025 | 1123 | 6.320 |
Why?
| | Surgeons | 11 | 2026 | 335 | 4.620 |
Why?
| | Physicians, Women | 5 | 2026 | 87 | 3.220 |
Why?
| | Neoplasm Staging | 24 | 2025 | 1398 | 2.710 |
Why?
| | Databases, Factual | 17 | 2025 | 1444 | 2.090 |
Why?
| | Esophageal Neoplasms | 12 | 2025 | 333 | 2.080 |
Why?
| | Esophagectomy | 12 | 2024 | 137 | 1.960 |
Why?
| | Societies, Medical | 9 | 2025 | 855 | 1.530 |
Why?
| | Chemotherapy, Adjuvant | 8 | 2022 | 378 | 1.180 |
Why?
| | Leadership | 2 | 2025 | 396 | 1.180 |
Why?
| | Career Choice | 5 | 2026 | 232 | 1.160 |
Why?
| | Registries | 5 | 2025 | 2135 | 1.100 |
Why?
| | Lymph Node Excision | 4 | 2025 | 169 | 0.980 |
Why?
| | Humans | 107 | 2026 | 141187 | 0.940 |
Why?
| | Treatment Outcome | 33 | 2025 | 11120 | 0.930 |
Why?
| | Aged | 49 | 2026 | 24574 | 0.910 |
Why?
| | Postoperative Complications | 18 | 2025 | 2797 | 0.900 |
Why?
| | Mentors | 2 | 2025 | 210 | 0.890 |
Why?
| | Biomedical Research | 3 | 2025 | 703 | 0.880 |
Why?
| | Organizational Culture | 1 | 2026 | 162 | 0.870 |
Why?
| | Retrospective Studies | 46 | 2026 | 16273 | 0.860 |
Why?
| | Laparoscopy | 6 | 2024 | 463 | 0.860 |
Why?
| | Bone Neoplasms | 4 | 2023 | 253 | 0.860 |
Why?
| | Intraoperative Complications | 1 | 2025 | 148 | 0.840 |
Why?
| | Survival Rate | 14 | 2025 | 1970 | 0.840 |
Why?
| | Middle Aged | 47 | 2026 | 34434 | 0.830 |
Why?
| | Spouses | 1 | 2025 | 108 | 0.830 |
Why?
| | Quality Improvement | 7 | 2025 | 1244 | 0.820 |
Why?
| | Workplace | 1 | 2026 | 269 | 0.820 |
Why?
| | Periodicals as Topic | 2 | 2024 | 217 | 0.820 |
Why?
| | Specialties, Surgical | 2 | 2023 | 80 | 0.810 |
Why?
| | Adenocarcinoma | 3 | 2024 | 892 | 0.800 |
Why?
| | Propensity Score | 5 | 2025 | 328 | 0.800 |
Why?
| | Risk Assessment | 11 | 2025 | 3490 | 0.780 |
Why?
| | Guideline Adherence | 4 | 2024 | 565 | 0.760 |
Why?
| | Lung Transplantation | 1 | 2025 | 322 | 0.720 |
Why?
| | Lymph Nodes | 3 | 2025 | 502 | 0.700 |
Why?
| | Clinical Decision-Making | 3 | 2020 | 339 | 0.680 |
Why?
| | Time-to-Treatment | 5 | 2025 | 217 | 0.680 |
Why?
| | Social Class | 2 | 2020 | 268 | 0.670 |
Why?
| | Cisplatin | 1 | 2022 | 327 | 0.660 |
Why?
| | Male | 54 | 2026 | 69783 | 0.660 |
Why?
| | Physician Executives | 1 | 2020 | 31 | 0.660 |
Why?
| | Family | 1 | 2025 | 680 | 0.660 |
Why?
| | Female | 56 | 2026 | 75515 | 0.650 |
Why?
| | Mesothelioma | 1 | 2020 | 46 | 0.610 |
Why?
| | Congresses as Topic | 1 | 2020 | 230 | 0.600 |
Why?
| | Burnout, Professional | 1 | 2026 | 455 | 0.600 |
Why?
| | Ischemic Preconditioning | 3 | 2024 | 50 | 0.590 |
Why?
| | Chemoradiotherapy | 2 | 2017 | 232 | 0.590 |
Why?
| | United States | 24 | 2026 | 15220 | 0.580 |
Why?
| | Internship and Residency | 4 | 2023 | 1235 | 0.580 |
Why?
| | Hernia, Hiatal | 3 | 2023 | 40 | 0.570 |
Why?
| | California | 5 | 2020 | 462 | 0.570 |
Why?
| | Survival Analysis | 6 | 2021 | 1319 | 0.560 |
Why?
| | Carcinoid Tumor | 1 | 2017 | 23 | 0.550 |
Why?
| | Health Services Research | 1 | 2020 | 406 | 0.550 |
Why?
| | Matched-Pair Analysis | 1 | 2017 | 38 | 0.520 |
Why?
| | Anastomotic Leak | 4 | 2024 | 43 | 0.520 |
Why?
| | Respiratory Function Tests | 2 | 2025 | 567 | 0.510 |
Why?
| | Time Factors | 11 | 2024 | 6956 | 0.510 |
Why?
| | Sexual and Gender Minorities | 1 | 2020 | 234 | 0.510 |
Why?
| | Esophageal Perforation | 2 | 2017 | 15 | 0.500 |
Why?
| | Small Cell Lung Carcinoma | 3 | 2023 | 116 | 0.490 |
Why?
| | Neoplasm Invasiveness | 5 | 2022 | 509 | 0.480 |
Why?
| | Practice Management, Medical | 1 | 2015 | 34 | 0.470 |
Why?
| | Critical Pathways | 1 | 2017 | 106 | 0.470 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 337 | 0.460 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 44 | 0.460 |
Why?
| | Accreditation | 1 | 2015 | 92 | 0.450 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2024 | 179 | 0.450 |
Why?
| | Mediastinoscopy | 1 | 2014 | 5 | 0.430 |
Why?
| | Hypothermia | 2 | 2025 | 45 | 0.430 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2014 | 45 | 0.420 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 1787 | 0.410 |
Why?
| | Thoracic Neoplasms | 3 | 2020 | 39 | 0.400 |
Why?
| | Pleural Neoplasms | 1 | 2013 | 27 | 0.400 |
Why?
| | Prognosis | 9 | 2025 | 4073 | 0.390 |
Why?
| | Chest Tubes | 1 | 2013 | 30 | 0.390 |
Why?
| | Sexism | 2 | 2026 | 68 | 0.390 |
Why?
| | Pneumothorax | 1 | 2013 | 47 | 0.380 |
Why?
| | Drainage | 2 | 2013 | 174 | 0.380 |
Why?
| | Education, Medical | 1 | 2015 | 270 | 0.380 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 1171 | 0.370 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 1597 | 0.370 |
Why?
| | Qualitative Research | 3 | 2026 | 1516 | 0.370 |
Why?
| | Respiratory Physiological Phenomena | 1 | 2011 | 35 | 0.360 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2011 | 45 | 0.360 |
Why?
| | Predictive Value of Tests | 5 | 2026 | 2070 | 0.350 |
Why?
| | Practice Patterns, Physicians' | 1 | 2020 | 1336 | 0.350 |
Why?
| | Esophagus | 2 | 2021 | 257 | 0.350 |
Why?
| | Salvage Therapy | 1 | 2011 | 153 | 0.340 |
Why?
| | Kaplan-Meier Estimate | 4 | 2020 | 908 | 0.330 |
Why?
| | Benchmarking | 2 | 2023 | 188 | 0.330 |
Why?
| | Device Removal | 1 | 2011 | 140 | 0.330 |
Why?
| | Biopsy | 2 | 2014 | 1081 | 0.330 |
Why?
| | Lymphatic Metastasis | 4 | 2025 | 326 | 0.330 |
Why?
| | Anastomosis, Surgical | 3 | 2024 | 159 | 0.330 |
Why?
| | Risk Factors | 10 | 2024 | 10438 | 0.320 |
Why?
| | Follow-Up Studies | 11 | 2025 | 5200 | 0.320 |
Why?
| | Precision Medicine | 1 | 2014 | 434 | 0.310 |
Why?
| | Length of Stay | 6 | 2024 | 1254 | 0.300 |
Why?
| | Antineoplastic Agents | 2 | 2020 | 2166 | 0.300 |
Why?
| | Preoperative Care | 1 | 2011 | 371 | 0.300 |
Why?
| | Adult | 15 | 2026 | 39177 | 0.300 |
Why?
| | Stents | 2 | 2017 | 529 | 0.290 |
Why?
| | Interpersonal Relations | 2 | 2025 | 411 | 0.270 |
Why?
| | Triage | 2 | 2020 | 246 | 0.270 |
Why?
| | Gene Expression Profiling | 1 | 2014 | 1764 | 0.260 |
Why?
| | Peer Review, Research | 2 | 2017 | 42 | 0.260 |
Why?
| | Catheter Ablation | 2 | 2023 | 313 | 0.250 |
Why?
| | Editorial Policies | 2 | 2017 | 52 | 0.250 |
Why?
| | Thoracotomy | 2 | 2020 | 80 | 0.250 |
Why?
| | Patient Selection | 3 | 2020 | 688 | 0.240 |
Why?
| | Aldosterone | 1 | 2026 | 43 | 0.240 |
Why?
| | Hyperaldosteronism | 1 | 2026 | 12 | 0.240 |
Why?
| | Adrenal Glands | 1 | 2026 | 80 | 0.240 |
Why?
| | Palliative Care | 5 | 2023 | 817 | 0.230 |
Why?
| | Smoking | 3 | 2024 | 1601 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 374 | 0.220 |
Why?
| | Radiosurgery | 2 | 2022 | 392 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 371 | 0.220 |
Why?
| | Patient Advocacy | 1 | 2025 | 76 | 0.220 |
Why?
| | Vulnerable Populations | 1 | 2025 | 169 | 0.210 |
Why?
| | Age Factors | 4 | 2026 | 3292 | 0.210 |
Why?
| | Job Satisfaction | 1 | 2026 | 221 | 0.200 |
Why?
| | Esophageal Stenosis | 1 | 2024 | 55 | 0.200 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1261 | 0.200 |
Why?
| | Esophagoscopy | 2 | 2017 | 213 | 0.200 |
Why?
| | Disease-Free Survival | 2 | 2016 | 715 | 0.200 |
Why?
| | Perioperative Care | 1 | 2025 | 227 | 0.200 |
Why?
| | Sex Factors | 3 | 2020 | 2058 | 0.190 |
Why?
| | Sex Distribution | 2 | 2020 | 379 | 0.190 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2024 | 183 | 0.190 |
Why?
| | Neoadjuvant Therapy | 5 | 2024 | 419 | 0.190 |
Why?
| | Aged, 80 and over | 8 | 2025 | 7856 | 0.190 |
Why?
| | North America | 1 | 2022 | 306 | 0.180 |
Why?
| | Social Determinants of Health | 1 | 2025 | 269 | 0.180 |
Why?
| | Carcinoma, Signet Ring Cell | 1 | 2021 | 17 | 0.180 |
Why?
| | Cohort Studies | 3 | 2017 | 5799 | 0.180 |
Why?
| | Patient Participation | 1 | 2025 | 432 | 0.170 |
Why?
| | Robotic Surgical Procedures | 1 | 2023 | 149 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 433 | 0.170 |
Why?
| | Radiation Oncology | 1 | 2021 | 86 | 0.170 |
Why?
| | Vertebroplasty | 2 | 2019 | 5 | 0.170 |
Why?
| | Medical Oncology | 2 | 2021 | 316 | 0.170 |
Why?
| | Administrative Claims, Healthcare | 1 | 2020 | 26 | 0.170 |
Why?
| | Data Warehousing | 1 | 2020 | 5 | 0.170 |
Why?
| | Fellowships and Scholarships | 2 | 2023 | 319 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2024 | 1306 | 0.170 |
Why?
| | Betacoronavirus | 2 | 2020 | 276 | 0.160 |
Why?
| | Biological Therapy | 1 | 2020 | 27 | 0.160 |
Why?
| | Logistic Models | 2 | 2017 | 2086 | 0.160 |
Why?
| | Risk Adjustment | 1 | 2020 | 81 | 0.160 |
Why?
| | Paraneoplastic Syndromes | 1 | 2019 | 12 | 0.160 |
Why?
| | Thymoma | 1 | 2019 | 36 | 0.160 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5636 | 0.160 |
Why?
| | Cultural Diversity | 1 | 2020 | 83 | 0.160 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2020 | 88 | 0.160 |
Why?
| | Data Mining | 1 | 2020 | 118 | 0.150 |
Why?
| | Incidence | 3 | 2023 | 2794 | 0.150 |
Why?
| | Jejunostomy | 2 | 2010 | 13 | 0.150 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 36 | 0.150 |
Why?
| | Imidazoles | 1 | 2020 | 244 | 0.150 |
Why?
| | Photochemotherapy | 1 | 2019 | 39 | 0.150 |
Why?
| | Medically Uninsured | 1 | 2020 | 136 | 0.150 |
Why?
| | Stomach | 3 | 2024 | 110 | 0.150 |
Why?
| | Solitary Fibrous Tumor, Pleural | 1 | 2018 | 4 | 0.150 |
Why?
| | Pleura | 1 | 2018 | 27 | 0.150 |
Why?
| | Pain | 2 | 2023 | 781 | 0.150 |
Why?
| | Medicare | 1 | 2024 | 799 | 0.150 |
Why?
| | Herniorrhaphy | 3 | 2023 | 76 | 0.140 |
Why?
| | Patient Discharge | 1 | 2024 | 932 | 0.140 |
Why?
| | Combined Modality Therapy | 2 | 2020 | 1243 | 0.140 |
Why?
| | Thoracic Wall | 1 | 2017 | 19 | 0.140 |
Why?
| | Spine | 1 | 2019 | 180 | 0.130 |
Why?
| | Education, Medical, Graduate | 2 | 2021 | 522 | 0.130 |
Why?
| | Quebec | 1 | 2017 | 10 | 0.130 |
Why?
| | Pain, Intractable | 1 | 2017 | 10 | 0.130 |
Why?
| | Lung | 3 | 2025 | 4134 | 0.130 |
Why?
| | Students, Medical | 1 | 2022 | 364 | 0.130 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2020 | 353 | 0.130 |
Why?
| | Area Under Curve | 1 | 2017 | 324 | 0.130 |
Why?
| | Interviews as Topic | 1 | 2020 | 844 | 0.130 |
Why?
| | Esophageal Diseases | 1 | 2017 | 28 | 0.130 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2020 | 289 | 0.130 |
Why?
| | Bone Cements | 1 | 2017 | 41 | 0.130 |
Why?
| | Mediastinum | 1 | 2016 | 22 | 0.130 |
Why?
| | Data Accuracy | 1 | 2017 | 65 | 0.130 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 655 | 0.130 |
Why?
| | Sacrum | 1 | 2017 | 71 | 0.120 |
Why?
| | Medical Records | 1 | 2017 | 182 | 0.120 |
Why?
| | Hospital Costs | 1 | 2017 | 122 | 0.120 |
Why?
| | Prospective Studies | 5 | 2024 | 7739 | 0.120 |
Why?
| | Patient Readmission | 2 | 2023 | 706 | 0.120 |
Why?
| | ROC Curve | 1 | 2017 | 586 | 0.120 |
Why?
| | Writing | 1 | 2017 | 101 | 0.120 |
Why?
| | Bayes Theorem | 1 | 2017 | 417 | 0.120 |
Why?
| | Elective Surgical Procedures | 1 | 2017 | 194 | 0.120 |
Why?
| | Cause of Death | 1 | 2017 | 440 | 0.120 |
Why?
| | Staff Development | 1 | 2015 | 60 | 0.110 |
Why?
| | Career Mobility | 1 | 2015 | 69 | 0.110 |
Why?
| | Radiation Pneumonitis | 1 | 2015 | 31 | 0.110 |
Why?
| | Guidelines as Topic | 1 | 2017 | 273 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2017 | 250 | 0.110 |
Why?
| | Cardiac Surgical Procedures | 1 | 2020 | 585 | 0.110 |
Why?
| | Military Medicine | 1 | 2016 | 130 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2018 | 431 | 0.110 |
Why?
| | Mental Disorders | 1 | 2023 | 1120 | 0.110 |
Why?
| | Goals | 1 | 2015 | 179 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2020 | 740 | 0.110 |
Why?
| | Pandemics | 4 | 2025 | 1653 | 0.100 |
Why?
| | Consensus | 3 | 2023 | 704 | 0.100 |
Why?
| | Pleural Effusion, Malignant | 1 | 2013 | 12 | 0.100 |
Why?
| | Hemothorax | 1 | 2013 | 13 | 0.100 |
Why?
| | Chylothorax | 1 | 2013 | 20 | 0.100 |
Why?
| | Empyema | 1 | 2013 | 8 | 0.100 |
Why?
| | Cooperative Behavior | 1 | 2015 | 462 | 0.100 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 802 | 0.100 |
Why?
| | Clinical Protocols | 2 | 2024 | 273 | 0.100 |
Why?
| | Paraganglioma, Extra-Adrenal | 1 | 2012 | 6 | 0.090 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 434 | 0.090 |
Why?
| | Thoracic Cavity | 1 | 2011 | 2 | 0.090 |
Why?
| | Surveys and Questionnaires | 1 | 2025 | 5929 | 0.090 |
Why?
| | Morbidity | 2 | 2023 | 322 | 0.090 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 898 | 0.090 |
Why?
| | Stomach Rupture | 1 | 2011 | 3 | 0.090 |
Why?
| | Heart Neoplasms | 1 | 2012 | 56 | 0.090 |
Why?
| | Fractures, Bone | 1 | 2017 | 404 | 0.090 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1396 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2019 | 1073 | 0.090 |
Why?
| | Negative-Pressure Wound Therapy | 1 | 2011 | 29 | 0.090 |
Why?
| | Heart Atria | 1 | 2012 | 139 | 0.090 |
Why?
| | Equipment Design | 1 | 2013 | 525 | 0.090 |
Why?
| | Molecular Targeted Therapy | 1 | 2014 | 419 | 0.080 |
Why?
| | Prosthesis Failure | 1 | 2011 | 125 | 0.080 |
Why?
| | Quality of Health Care | 1 | 2015 | 658 | 0.080 |
Why?
| | Supine Position | 1 | 2010 | 38 | 0.080 |
Why?
| | Patient Care Team | 1 | 2015 | 664 | 0.080 |
Why?
| | Gastrectomy | 1 | 2011 | 133 | 0.080 |
Why?
| | Patient Positioning | 1 | 2010 | 70 | 0.080 |
Why?
| | Feasibility Studies | 1 | 2014 | 1018 | 0.080 |
Why?
| | Genomics | 1 | 2015 | 814 | 0.080 |
Why?
| | Suture Techniques | 1 | 2010 | 128 | 0.080 |
Why?
| | Aorta | 1 | 2012 | 421 | 0.080 |
Why?
| | Gastrostomy | 1 | 2010 | 122 | 0.070 |
Why?
| | Military Personnel | 1 | 2016 | 613 | 0.070 |
Why?
| | Sarcoma | 1 | 2011 | 190 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 319 | 0.070 |
Why?
| | Immunotherapy | 2 | 2023 | 640 | 0.060 |
Why?
| | Radiography, Interventional | 1 | 2007 | 122 | 0.060 |
Why?
| | Veins | 1 | 2026 | 70 | 0.060 |
Why?
| | Quality of Life | 3 | 2023 | 2999 | 0.060 |
Why?
| | Lung Diseases | 1 | 2011 | 794 | 0.060 |
Why?
| | Forced Expiratory Volume | 1 | 2025 | 489 | 0.050 |
Why?
| | Neoplasms | 1 | 2019 | 2741 | 0.050 |
Why?
| | Emergencies | 1 | 2025 | 179 | 0.050 |
Why?
| | Constriction, Pathologic | 1 | 2024 | 238 | 0.050 |
Why?
| | Carbon Monoxide | 1 | 2023 | 83 | 0.050 |
Why?
| | Hospitalization | 2 | 2023 | 2255 | 0.050 |
Why?
| | Reoperation | 2 | 2017 | 588 | 0.050 |
Why?
| | Forecasting | 1 | 2023 | 384 | 0.040 |
Why?
| | Surgical Mesh | 1 | 2021 | 52 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2022 | 131 | 0.040 |
Why?
| | Cementoplasty | 1 | 2020 | 2 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2025 | 550 | 0.040 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2020 | 219 | 0.040 |
Why?
| | Kyphoplasty | 1 | 2019 | 7 | 0.040 |
Why?
| | Brachytherapy | 1 | 2020 | 130 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2011 | 2087 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2021 | 309 | 0.040 |
Why?
| | Pain Measurement | 1 | 2020 | 554 | 0.030 |
Why?
| | Health Services Needs and Demand | 1 | 2020 | 286 | 0.030 |
Why?
| | Reproducibility of Results | 1 | 2026 | 3348 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 395 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 382 | 0.030 |
Why?
| | Occupational Health | 1 | 2020 | 208 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2902 | 0.030 |
Why?
| | Europe | 1 | 2017 | 410 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 171 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 335 | 0.030 |
Why?
| | Canada | 1 | 2017 | 428 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2024 | 3588 | 0.030 |
Why?
| | Young Adult | 3 | 2019 | 13673 | 0.030 |
Why?
| | Anniversaries and Special Events | 1 | 2016 | 17 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2022 | 666 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 868 | 0.030 |
Why?
| | Data Interpretation, Statistical | 1 | 2017 | 376 | 0.030 |
Why?
| | History, 21st Century | 1 | 2016 | 220 | 0.030 |
Why?
| | History, 20th Century | 1 | 2016 | 329 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 367 | 0.030 |
Why?
| | Child, Preschool | 2 | 2019 | 11457 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2015 | 600 | 0.020 |
Why?
| | Clinical Competence | 1 | 2021 | 1202 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2021 | 1116 | 0.020 |
Why?
| | Abdomen, Acute | 1 | 2011 | 22 | 0.020 |
Why?
| | Neoplasm, Residual | 1 | 2012 | 132 | 0.020 |
Why?
| | Transplantation, Autologous | 1 | 2012 | 280 | 0.020 |
Why?
| | Laparotomy | 1 | 2011 | 115 | 0.020 |
Why?
| | Lymphoma, B-Cell | 1 | 2011 | 130 | 0.020 |
Why?
| | Coronary Angiography | 1 | 2012 | 316 | 0.020 |
Why?
| | Adolescent | 2 | 2019 | 22007 | 0.020 |
Why?
| | Child | 2 | 2019 | 22308 | 0.020 |
Why?
| | Wound Healing | 1 | 2011 | 348 | 0.020 |
Why?
| | Gastric Outlet Obstruction | 1 | 2007 | 12 | 0.020 |
Why?
| | Intestinal Obstruction | 1 | 2007 | 52 | 0.020 |
Why?
| | Fluoroscopy | 1 | 2007 | 169 | 0.020 |
Why?
| | Digestive System Surgical Procedures | 1 | 2007 | 109 | 0.020 |
Why?
| | Ultrasonography, Interventional | 1 | 2007 | 155 | 0.020 |
Why?
| | Stomach Neoplasms | 1 | 2007 | 118 | 0.020 |
Why?
| | Infant | 1 | 2019 | 9818 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2892 | 0.010 |
Why?
| | Mice | 1 | 2015 | 18048 | 0.010 |
Why?
| | Animals | 1 | 2015 | 37657 | 0.010 |
Why?
| | Carcinoma, Bronchogenic | 1 | 1970 | 20 | 0.010 |
Why?
| | Bronchial Neoplasms | 1 | 1970 | 16 | 0.010 |
Why?
| | Hemoptysis | 1 | 1970 | 37 | 0.000 |
Why?
| | Cough | 1 | 1970 | 129 | 0.000 |
Why?
| | Bronchoscopy | 1 | 1970 | 226 | 0.000 |
Why?
| | Bronchi | 1 | 1970 | 270 | 0.000 |
Why?
| | Sputum | 1 | 1970 | 309 | 0.000 |
Why?
|
|
David's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|